VPS35 promotes tumor proliferation and migration through the PPARs-ACSL1/4 pathway in lung adenocarcinoma.

Wen K, Yu X, Yu J, Li H, Zhan Y.

Open source

DOI
10.1016/j.intimp.2026.116849
Published
2026-05-15
Container
Int Immunopharmacol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.116849,
  title = {VPS35 promotes tumor proliferation and migration through the PPARs-ACSL1/4 pathway in lung adenocarcinoma.},
  author = {Wen K and  Yu X and  Yu J and  Li H and  Zhan Y.},
  year = {2026},
  journal = {Int Immunopharmacol},
  doi = {10.1016/j.intimp.2026.116849},
  url = {https://doi.org/10.1016/j.intimp.2026.116849}
}

RIS

TY  - JOUR
TI  - VPS35 promotes tumor proliferation and migration through the PPARs-ACSL1/4 pathway in lung adenocarcinoma.
AU  - Wen K
AU  -  Yu X
AU  -  Yu J
AU  -  Li H
AU  -  Zhan Y.
PY  - 2026
JO  - Int Immunopharmacol
DO  - 10.1016/j.intimp.2026.116849
UR  - https://doi.org/10.1016/j.intimp.2026.116849
ER  - 

APA

K, W., X, Y., J, Y., H, L., & Y., Z. (2026). VPS35 promotes tumor proliferation and migration through the PPARs-ACSL1/4 pathway in lung adenocarcinoma.. Int Immunopharmacol. https://doi.org/10.1016/j.intimp.2026.116849

Source records